South Korean prosecutors are attempting for a second time to arrest Samsung’s de facto leader, who faces bribery allegations in connection with a massive political scandal.
Special prosecutors investigating the influence-peddling scandal that led to the impeachment of the president said Tuesday they have asked a court to issue an arrest warrant for Lee Jae-yong, the vice chairman of Samsung Electronics. They also are seeking an arrest warrant for Samsung Electronics President Park Sang-jin, who oversees the company’s external relations.
Seoul Central District Court said it will hold a hearing on Thursday to review the arrest request.
This is the second attempt by prosecutors to arrest Lee, the heir to the Samsung. Last month, a court said there was not enough evidence to justify Lee’s arrest at that point.
The prosecutors argued that the 48-year-old billionaire offered a bribe of $36 million to President Park Geun-hye and her long-time friend to win government backing for a controversial merger.
The merger of Samsung C&T and Cheil Industries in 2015 was opposed by minority shareholders, who said it would benefit the Samsung founding family while hurting other shareholders. Samsung narrowly secured shareholder approval, thanks in part to support from the National Pension Fund, its key investor.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas